Access to anti-retroviral drugs, male in Peru
Peru: Access to anti-retroviral drugs, male was 79.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Peru, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Peru stood at 79.0%. That is the highest value across all 25 years on record.
The figure is up 5.3% on the previous year and up 102.6% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Peru peaked at 79.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Peru 49th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Peru, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 1.0% | — |
| 2003 | 3.0% | +200.0% |
| 2004 | 2.0% | -33.3% |
| 2005 | 5.0% | +150.0% |
| 2006 | 8.0% | +60.0% |
| 2007 | 11.0% | +37.5% |
| 2008 | 13.0% | +18.2% |
| 2009 | 19.0% | +46.2% |
| 2010 | 27.0% | +42.1% |
| 2011 | 28.0% | +3.7% |
| 2012 | 35.0% | +25.0% |
| 2013 | 35.0% | +0.0% |
| 2014 | 39.0% | +11.4% |
| 2015 | 38.0% | -2.6% |
| 2016 | 48.0% | +26.3% |
| 2017 | 53.0% | +10.4% |
| 2018 | 60.0% | +13.2% |
| 2019 | 68.0% | +13.3% |
| 2020 | 69.0% | +1.5% |
| 2021 | 73.0% | +5.8% |
| 2022 | 76.0% | +4.1% |
| 2023 | 75.0% | -1.3% |
| 2024 | 79.0% | +5.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.2% | 0.0% | 19.0% | 10 |
| 2010s | 43.1% | 27.0% | 68.0% | 10 |
| 2020s | 74.4% | 69.0% | 79.0% | 5 |
Countries ranked near Peru
More gender data for Peru
- Child population (UN estimates and projections) 7,988 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.3909 % change on previous year (2030)
- Population 28,205 (2030)
- Working-age population (UN estimates and projections) 28,205 (2030)
- Population (UN estimates and projections), annual growth rate 1.2 % change on previous year (2030)
- Age population, age 00, female, interpolated 261,493 (2025)
- Age population, age 00, male, interpolated 271,554 (2025)
- Age population, age 01, female, interpolated 262,030 (2025)
- Age population, age 01, male, interpolated 271,974 (2025)
- Age population, age 02, female, interpolated 262,425 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Peru?
- Access to anti-retroviral drugs, male in Peru was 79.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Peru?
- The highest recorded value was 79.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Peru?
- The lowest recorded value was 0.0% in 2000.
- How does Peru rank for access to anti-retroviral drugs, male?
- Peru ranks 49th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Peru?
- Over the last ten years it is up 102.6%. The long-run trend across the full record is volatile.
- Where does this Peru data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.